Integrity Applications, Inc. Share Price Other OTC
Equities
IGAP
US45824Q1013
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.46M 456M |
---|---|---|---|---|---|
Net income 2022 | -4M -334M | Net income 2023 | -7M -584M | EV / Sales 2022 | - |
Net cash position 2022 | 2.12M 177M | Net cash position 2023 | 4.3M 359M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.92
x | P/E ratio 2023 |
-0.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.57% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Goode
CEO | Chief Executive Officer | 56 | 17/20/17 |
James Cardwell
DFI | Director of Finance/CFO | 64 | 11/23/11 |
David Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Drew Sycoff
BRD | Director/Board Member | 57 | 08/19/08 |
Luis Malavé
CHM | Chairman | 61 | 13/02 |
Robert Fischell
BRD | Director/Board Member | 95 | 01/10/01 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |